What is Newleos Therapeutics worth?
$150.0Mlast known valuation
Newleos Therapeutics last raised $93.4M in its Later Stage VC (Feb 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Newleos Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2025 | Later Stage VC | $93.4M | ▮ | ▮ |
How Newleos Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Newleos Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Newleos Therapeutics worth?
- Newleos Therapeutics's last known valuation is $150.0M.
- How much has Newleos Therapeutics raised?
- Newleos Therapeutics has raised $93.5M in total funding across 1 recorded rounds.
- When did Newleos Therapeutics last raise?
- Newleos Therapeutics last raised in Feb 2025 (Later Stage VC), raising $93.4M.